GITR and Targeted Small Molecules for Cancer Immunotherapy

<p style="margin-left:0cm; margin-right:0cm">While revolutionary cancer treatments see progress every day, cancer still remains a severe problem in our world. Immune checkpoint inhibitors, an advanced form of immunotherapy, is a treatment utilizing small molecules to override immune system checkpoints and enhance immun

Authors

Venkataraman Deepak (ORCID: https://orcid.org/0000-0003-1421-9030)

Publication Details

Journal: European Journal of Biomedical and Life Sciences
Published: 2025-10-26
DOI: https://doi.org/10.29013/ejbls-25-3-12-29
Primary Topic: Chemokine receptors and signaling
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

GITR and Targeted Small Molecules for Cancer Immunotherapy

Venkataraman Deepak

Oct 26, 2025

European Journal of Biomedical and Life Sciences

Chemokine receptors and signaling

article

GITR and Targeted Small Molecules for Cancer Immunotherapy

Venkataraman Deepak

October 26, 2025article en

Abstract

European Journal of Biomedical and Life Sciences

Openalex Percentile: Top 58%

Chemokine receptors and signaling

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GITR and Targeted Small Molecules for Cancer Immunotherapy — Venkataraman Deepak · European Journal of Biomedical and Life Sciences (2025) | TGRS Research Map | TGRS